Study of Metastatic Ocular Melanoma
This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.
Ocular Melanoma
DRUG: Gemcitabine|DRUG: Treosulfan
Determination of efficacy according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria
Time to progression
Treatment of patients with metastatic ocular melanoma with combination chemotherapy Gemcitabine and Treosulfan versus monotherapy with Treosulfan as first-line chemotherapy.